MAS vs TERN · P/E 18, rev $7.83B vs $6.12B cap
Masco Corporation (MAS) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
MAS currently screens at market cap $14.00B and trailing P/E 18.1. TERN currently screens at market cap $6.12B.
Not investment advice. Open the MAS and TERN stock pages for the full models.
Not investment advice.